Biotechnology - Publications - Faculty & Research

January 2007 (Revised January 2007)
Background Note

Note on the U.S. Food and Drug Administration

By: Robert F. Higgins, Richard G. Hamermesh and Virginia Fuller

Describes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure. View Details

Keywords: Health; Governance Compliance; Policy; Product Development; Government and Politics; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; United States

Citation

Educators

Purchase

Article

What to Know About Locating in a Cluster

By: Willy C. Shih and Sen Chai

As a study of two industry clusters in Denmark shows, factors that can make clusters attractive—easy people movement and knowledge spillovers—can also make it harder for individual companies to retain proprietary knowledge. View Details

Keywords: Clusters; Clustering; Competitiveness; Life Sciences; Telecommunications; Science-based; Research And Development; Industry Clusters; Research; Innovation Strategy; Innovation and Management; Geographic Location; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Denmark

Citation

Register to Read

February 2014
Case

BGI: Data-driven Research

By: Willy Shih and Sen Chai

BGI has the largest installed gene-sequencing capacity in the world, and to Zhang Gengyun, general manager of the Life Sciences Division, this represented an opportunity to apply his training as a plant breeder and his early career work as a biochemist to improving... View Details

Citation

Educators

Purchase

September 2009 (Revised December 2009)
Supplement

Genzyme Center (C)

By: Michael W. Toffel and Aldo Sesia

Genzyme Corporation is in the midst of planning its new corporate headquarters, which incorporates many innovative green building features. After learning that the building as planned would likely earn a LEED Silver rating, an intermediate score in the LEED green... View Details

Keywords: Environmental Sustainability; Corporate Social Responsibility and Impact; Standards; Cost vs Benefits; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry

Citation

Purchase

Web

Dean Srikant Datar’s 2023 Commencement Remarks | About

join the biotechnology firm Vertex, where she led teams to make innovative medicines that treat chronic diseases like cystic fibrosis. Amid a busy career, Depelsha McGruder acted courageously to launch Moms of Black Boys United to... View Details

03 Sep 2013
First Look

First Look: September 3

results. Purchase this case: http://hbr.org/search/713537-PDF-ENG Harvard Business School Case 814-014 Sample6: Innovating to Make Food Safer Tim Curran, CEO of Sample6, a start-up biotechnology company developing a novel food safety... View Details

Keywords: Sean Silverthorne

March 2014
Module Note

Implementing Environmentally Sustainable Operations

By: Michael W. Toffel

Citation

Purchase

14 Sep 2010
First Look

First Look: September 14, 2010

involved in the production of clean energy. One of the key bottlenecks threatening innovation in energy production is the inability of VCs to exit their investments at the appropriate time. This hurdle did exist in industries such as View Details

Keywords: Sean Silverthorne

12 Oct 2006
First Look

First Look: October 12, 2006

http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707438 PublicationsScience Business: Promise, Performance and the Future of Biotech Author:Gary P. Pisano Publication:Harvard Business School Press (forthcoming) Abstract Why has the View Details

Keywords: Sean Silverthorne

06 Jun 2017
First Look

First Look at New Research and Ideas: June 6, 2017

Pharmacyclics is a biotechnology company that had received FDA approval in late 2013 for its flagship asset Imbrivica (ibrutinib), a biologic treatment for chronic lymphocytic leukemia and two other even rarer blood malignancies. Entering... View Details

Keywords: Sean Silverthorne

Web

Winners & Success Stories | New Venture Competition

Pharmaceuticals Alec Machiels, MBA 2001 Potentia is a clinical-stage biotechnology company with a world-class scientific team and scientific advisory board. The company’s mission is to bring the first treatment targeting the root cause of... View Details

02 Feb 2016
First Look

February 2, 2016

agent-based simulation model of network emergence. Using data on technology partnerships from 1983 to 1999 among firms in the automotive, biotechnology and pharmaceuticals, chemicals, microelectronics, new materials, and... View Details

Keywords: Sean Silverthorne

15 Dec 2015
News

The Year in Ideas 2015

guilt and insecurity. NeuroPhage is a family business of sorts. Jonathan Solomon’s (MBA 2007) mother, Beka Solomon, chair for biotechnology of neurodegenerative diseases at Tel Aviv University, had spent years working with a virus that... View Details

Keywords: Julia Hanna, Christine Lejeune, Dan Morrell, and April White

06 Feb 2007
First Look

First Look: February 6, 2007

India, and asks if the world's leading biotechnology firm should develop similar delivery-based systems. Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=507018 RKS Guitars Harvard Business School Case... View Details

Keywords: Martha Lagace

03 May 2011
First Look

First Look: May 3

had more than doubled its profits, deposits and advances; regained market share and won the Asian Banker Achievement award for the strongest bank in the Asia Pacific region. Purchase this case:http://cb.hbsp.harvard.edu/cb/product/511114-PDF-ENG MorphoSys AG: The... View Details

Keywords: Sean Silverthorne

20 Nov 2006
Research & Ideas

Open Source Science: A New Model for Innovation

coming up with a solution that could be off-the-shelf. So when they actually see solutions from this type of method, they're blown away. Recently, an internal science team at a U.S.-based major biotechnology firm was assigned to develop a... View Details

Keywords: by Martha Lagace

23 Jan 2019
News

The Promise of Personalized Medicine

as a biotechnology company, Myofinity Biosciences. Those two organizations have taken two different paths. They’re not connected. The 501(c)(3), Terry’s Foundation (now Cure Rare Disease), is doing something incredibly unprecedented. What... View Details

2020
Book

Work, Mate, Marry, Love: How Machines Shape Our Human Destiny

By: Debora L. Spar

Covering a time frame that ranges from 8000 BC to the present, and drawing upon both Marxist and feminist theories, the book argues that nearly all the decisions we make in our most intimate lives—whom to marry, how to have children, how to have sex, how to think about... View Details

Citation

Purchase

October 2020 (Revised April 2022)
Case

When Institutions Fail: HIV/AIDS in the 1980s

By: Tom Nicholas and Christian Godwin

During the early 1980s, young gay men in urban centers such as San Francisco and New York City began contracting a mysterious illness that would come to be known as HIV/AIDS. A diagnosis meant almost certain death, with a less than 1% survival rate. Conflicting... View Details